Dark Forest Capital Management’s NovoCure NVCR Stock Holding History

Dark Forest Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$137K	Buy	+12,532	New	+$157K	0.01%	756
2025 Q4	–	Sell	-177,830	Closed	-$2.3M	–	1228
2025 Q3	$2.3M	Buy	+177,830	New	+$2.38M	0.09%	414
2025 Q2	–	Sell	-77,873	Closed	-$1.39M	–	1420
2025 Q1	$1.39M	Buy	+77,873	New	+$1.77M	0.06%	531
2022 Q3	–	Sell	-31	Closed	-$2K	–	1348
2022 Q2	$2K	Buy	+31	New	+$2.33K	﹤0.01%	735
2022 Q1	–	Sell	-170	Closed	-$13K	–	1610
2021 Q4	$13K	Buy	+170	New	+$17.1K	﹤0.01%	838

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Dark Forest Capital Management's NVCR Position: Q1 2026 in Review

Dark Forest Capital Management opened a new position in NovoCure (NVCR) in Q1 2026: 12,532 shares worth $137K. The stake represents 0.01% of the portfolio and ranks #756 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in NVCR as recently as Q3 2025.

Dark Forest Capital Management first reported a position in NVCR in Q4 2021 and has held it in 5 quarters since. The position peaked at $2.3M in Q3 2025. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Dark Forest Capital Management held 12,532 shares of NovoCure worth $137K as of Q1 2026.
NovoCure was a new Dark Forest Capital Management position in Q1 2026.
NovoCure made up 0.01% of Dark Forest Capital Management's portfolio in Q1 2026, its #756 holding.
Dark Forest Capital Management first reported a position in NovoCure in Q4 2021 and has held it in 5 quarters since.
Dark Forest Capital Management's NovoCure position peaked at $2.3M in Q3 2025.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.